CHEK1 and neuroblastoma: WEE1, CHEK1, BRCA1, FANCD2, PARP1, and phosphorylation of CHEK1 and ATR were significantly reduced in TRPM2 deleted neuroblastoma and myeloid leukemia cells after doxorubicin treatment.